Skip to content

NAC Supplementation and Soccer Specific Performance

Effects of NAC Supplementation on Immune Function, Inflammatory and Performance Responses of Elite Soccer Players Participated in Three Repetitive Games.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04523675
Enrollment
40
Registered
2020-08-21
Start date
2016-04-30
Completion date
2016-12-31
Last updated
2020-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antioxidant Status, Exercise-induced Aseptic Inflammation, Skeletal Muscle Damage, Skeletal Muscle Performance

Brief summary

In this investigation the investigators utilized NAC supplementation to boost GSH availability during an one-week-microcycle consisting of three soccer games, in order to test the hypotheses that: i) antioxidant supplementation may enhance the recovery of performance and physiological stress variables following multiple match-plays and ii) redox status perturbations are critical in regulating the inflammatory response and repair in skeletal muscle, following repetitive exercise-induced muscle injuries.

Detailed description

After exercise-induced muscle microtrauma the thiol/disulfide couple of reduced (GSH) and oxidized glutathione (GSSG) is a key regulator of important transcriptional pathways that control the inflammatory response and recovery of skeletal muscle. The objective was to examine how thiol-based antioxidant supplementation affects the muscle damage, oxidative stress, inflammatory and immune responses, as well as the level of post-game fatigue and muscle's recovery kinetics in response to three soccer games within a week. Participants were randomly assigned to one of four groups: i) Experimental-NAC \[EXP-NAC, N=10, participated in daily training sessions and three games and received NAC (20 mg/kg/day)\], ii) Experimental-Placebo (EXP-Pla, N=10, participated in daily training sessions and three games and received Placebo), iii) Control-NAC \[CON-NAC, N=10, participated in daily training sessions only and received NAC(20 mg/kg/day)\] and iv) Control-Placebo (CON-Pla, N=10, participated in daily training sessions only and received Placebo). Blood samples were collected at baseline, post-games and daily during recovery. Performance was assessed at baseline and daily during recovery.

Interventions

DIETARY_SUPPLEMENTN-acetylcysteine

Orally in three daily dosages (morning-midday-evening), at 20 mg/kg/day, for seven consecutive days.

DIETARY_SUPPLEMENTPlacebo

500 mL drink that contained water (375 mL), sugar-free cordial (125 ml), and 2 g of low-calorie glucose/dextrose powder. Orally in three daily dosages (morning-midday-evening), for seven consecutive days.

Sponsors

University of Thessaly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 28 Years
Healthy volunteers
Yes

Inclusion criteria

* Participation at elite level (top three division leagues) of soccer competition for at least five years * Abstained from consumption of performance-enhancing supplements, antioxidant supplements and medications (for at least 6 months before and during the study) * Participation in at least six two-hour training sessions and one match per week * Non-smokers

Exclusion criteria

* A known NAC intolerance or allergy * A recent febrile illness * History of muscle lesion * Lower limb trauma * Metabolic diseases

Design outcomes

Primary

MeasureTime frameDescription
Change in oxidized glutathione in red blood cellsAt baseline and daily throughout the study, up to 11 days
Change in creatine kinase in activity in plasmaAt baseline and daily throughout the study, up to 11 days
Change in total antioxidant capacity in serumAt baseline and daily throughout the study, up to 11 days
Change in reduced glutathione in red blood cellsAt baseline and daily throughout the study, up to 11 days
Change in protein carbonyls in serumAt baseline and daily throughout the study, up to 11 days
Change in thiobarbituric acid reactive substances in serumAt baseline and daily throughout the study, up to 11 days
Change in white blood cell count in bloodAt baseline and daily throughout the study, up to 11 days
Change in repeated sprint abilityAt baseline and daily throughout the study, up to 11 daysPlayers' repeated sprint ability was assessed via a repeared sprint test. Each player performed 5 x 30 meters sprints interspersed by 25 seconds of active recovery. Sprint time was recorded by using infrared photoelectrical gates.
Change in high intensity running during the gameDuring games 1, 2 and 3High intensity running (i.e. \> 14km/h) during the games was monitored by utilizing high time-resolution GPS devices.

Secondary

MeasureTime frame
Change in blood lactate concentration during the gameDuring games 1, 2 and 3
Change in average heart rate during the gameDuring games 1, 2 and 3

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026